Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins.
Open Access
- 1 July 1980
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 33 (7), 617-621
- https://doi.org/10.1136/jcp.33.7.617
Abstract
Fifty-six patients presenting with neurological complaints were found to have paraproteinaemia unassociated with immunocytic malignancy; 16 patients presented with peripheral neuropathy. There was an association between IgM paraproteinaemia and an idiopathic neuropathy with markedly slowed nerve conduction velocities.This publication has 38 references indexed in Scilit:
- THE SIGNIFICANCE OF PARAPROTEINAEMIA IN PATIENTS WITH PRIMARY NEUROLOGICAL SYMPTOMSActa Neurologica Scandinavica, 2009
- Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.Journal of Clinical Pathology, 1979
- Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 casesClinical Immunology and Immunopathology, 1978
- Peripheral neuropathy and benign IgG paraproteinaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- Clinical Features of Patients with a Serum M ComponentActa Medica Scandinavica, 1978
- The clinical correlates of IgM M-components: an analysis of thirty-four patientsThe American Journal of the Medical Sciences, 1975
- Benign paraproteinaemias.Journal of Clinical Pathology, 1975
- BENCE JONES PROTEINURIA IN BENIGN MONOCLONAL GAMMAPATHIESActa Medica Scandinavica, 1968
- Paraproteins, benign or malignant?BMJ, 1967
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966